The Team

Steve Ochoa
Steve Ochoa
CTO & Founder

CTO & Founder. Software engineer with a career shipping production systems at Quicken, Magnite, and MetricWorks. Leads Exigyn's agentic AI layer — the Excel and PowerPoint connectors that pull live planning data into the tools biotech finance teams already use. Bachelors in Computer Science from Oregon State.

Angus Hsu
Angus Hsu
VP, BD & Product

VP, BD & Product. Started in corporate finance at Wells Fargo before pivoting into healthcare, working across commercial and R&D finance in pharma and medical devices. Passionate about using the latest financial planning toolset to automate back-office modeling and deck creation — so finance teams can focus on the most strategic decisions possible. UC Berkeley, B.A. in Economics. MBA from UCLA

Advisors
Nathan Revel
Nathan RevelAdvisor

Biotech finance leader with 15+ years at Gilead Sciences, PwC, and BofA, plus operating finance roles at clinical-stage biotechs from IND through commercial launch. Built Exigyn because every FP&A tool he used was designed for SaaS — biotech deserved its own.

Steve Ochoa
Steve Ochoa
CTO & Founder

CTO & Founder. Software engineer with a career shipping production systems at Quicken, Magnite, and MetricWorks. Leads Exigyn's agentic AI layer — the Excel and PowerPoint connectors that pull live planning data into the tools biotech finance teams already use. Bachelors in Computer Science from Oregon State.

Angus Hsu
Angus Hsu
VP, BD & Product

VP, BD & Product. Started in corporate finance at Wells Fargo before pivoting into healthcare, working across commercial and R&D finance in pharma and medical devices. Passionate about using the latest financial planning toolset to automate back-office modeling and deck creation — so finance teams can focus on the most strategic decisions possible. UC Berkeley, B.A. in Economics. MBA from UCLA

Advisors
Nathan Revel
Nathan RevelAdvisor

Biotech finance leader with 15+ years at Gilead Sciences, PwC, and BofA, plus operating finance roles at clinical-stage biotechs from IND through commercial launch. Built Exigyn because every FP&A tool he used was designed for SaaS — biotech deserved its own.